Skip to content
Resources > Reports

Investment Banking Trends and Outlook for 2023

There’s no denying the harsh reality investment bankers are facing: struggling to get deals across the finish line while juggling to keep clients satisfied. With a volatile market afflicted by macroeconomic uncertainty, deals are harder to source, regulators are tightening up, the debt market remains closed, and the amount of reliable and unreliable data is nearly impossible to sort, let alone analyze manually.

Ultimately, these pressures have forced investment banks to keep up with the rapid technological advances that have accelerated the industry forward. Those who rely on outdated processes and resist change will soon be outpaced by progressive institutions, effectively losing out on new clients and talent.

But what does this new wave of technological adoption and doing business look like?

Download our report to learn:

  • The top trends defining the industry, Generative AI to Open Banking
  • What technologies leading nations are adopting to fight economic uncertainty
  • An outlook on the opportunities and challenges that will play out in the IB space

Explore more

APAC Macro Briefing 2026: Risk Meets Opportunity

In this report, we show how resources and workflows available in the AlphaSense platform can help contextualize the APAC macro environment, exploring the key implications for corporate leaders and investors across sectors.
Title slide for "APAC Macro Briefing 2026: Risk Meets Opportunity" with a map of the Asia-Pacific region.

Top AI Use Cases for Private Equity

In this report, discover how private equity teams are leveraging AI to accelerate conviction with speed. With purpose built, AI-driven solutions like AlphaSense, teams are gaining a competitive advantage with custom workflows and unmatched content sets for the most differentiated deal intelligence.
Top AI Use Cases For Private Equity by Barb Tague, Financial Research Leader. Illustration featuring isometric buildings and currency symbols.

AI in Drug Development 2026: From Experimentation to Execution

Learn how AI is reshaping drug development in real time, turning AI execution into a key competitive differentiator.
Presentation slide titled "AI in Drug Development 2026: From Experimentation to Execution" by Sara Mallatt and Sean Carmichael, with line art of laboratory equipment.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.